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Dynamin is a GTP-binding protein whose oligomeriz-
ation-dependent assembly around the necks of lipid
vesicles mediates their scission from parent membra-
nes. Dynamin is thus directly involved in the regulation
of endocytosis. Sumoylation is a post-translational pro-
tein modification whereby the ubiquitin-like modifier
Sumo is covalently attached to lysine residues on target
proteins by a process requiring the concerted action of
an activating enzyme (ubiquitin-activating enzyme), a
conjugating enzyme (ubiquitin carrier protein), and a
ligating enzyme (ubiquitin-protein isopeptide ligase).
Here, we show that dynamin interacts with Sumo-1,
Ubc9, and PIAS-1, all of which are members of the
sumoylation machinery. Ubc9 and PIAS-1 are known
ubiquitin carrier protein and ubiquitin-protein isopep-
tide ligase enzymes, respectively, for the process of
sumoylation. We have identified the coiled-coil GTPase
effector domain (GED) of dynamin as the site on dyna-
min that interacts with Sumo-1, Ubc9, and PIAS-1. Alt-
hough we saw no evidence of covalent Sumo-1 attac-
hment to dynamin, Sumo-1 and Ubc9 are shown here to
inhibit the lipid-dependent oligomerization of dynamin.
Expression of Sumo-1 and Ubc9 in mammalian cells
down-regulated the dynamin-mediated endocytosis of
transferrin, whereas dynamin-independent fluid-phase
uptake was not affected. Furthermore, using high resol-
ution NMR spectroscopy, we have identified amino acid
residues on Sumo-1 that directly interact with the GED
of dynamin. The results suggest that the GED of dyna-
min may serve as a scaffold that concentrates the
sumoylation machinery in the vicinity of potential acc-
eptor proteins.
The protein dynamin is an important component of the en-
docytic machinery in cells (1, 2). Dynamin isoforms are thought
to mediate their functions by virtue of their ability to aid in the
scission of vesicles from membranes (3). Mammalian dy-
namin-1 and dynamin-2 have been shown to have a role in the
scission of clathrin-coated vesicles and in the budding of caveo-
lae (4). The dynamin family can be considered to include clas-
sical dynamins as well as the dynamin-like mitochondrial di-
vision proteins Dnm1, Mgm1, and Fzo1 and the interferon-
inducible Mx and guanylate-binding proteins, which have been
shown to possess antiviral activities (5). The yeast Vps1 and
plant ARC5 and ADL proteins also belong to this family of
GTP-binding proteins (6). True dynamins are modular proteins
characterized by the presence of an N-terminal GTP-binding
domain, a contiguous “middle domain” of ill defined function,
and a lipid-binding pleckstrin homology (PH)1 domain, followed
by a coiled-coil “assembly” domain and a proline-rich domain
(PRD). Other dynamin-like proteins, e.g. Mx, lack the pleck-
strin homology and proline-rich domains. The GTPase domain
is the most highly conserved domain within members of the
dynamin family. The coiled-coil assembly domain has been
shown to mediate the assembly of dynamin into oligomers (7)
and has also been shown to possess an assembly-stimulated
GTPase-accelerating property for the GTPase domain. The oli-
gomerization of dynamin is critical for its function in mediating
the process of endocytosis (8). Dynamin-mediated endocytosis
is critical for synaptic vesicle recycling in the central nervous
system and for cell-surface receptor endocytosis in all cells of
an organism. GTP-bound dynamin is thought to assemble in
the form of rings around the necks of budding vesicles; a con-
formational change in the dynamin collar is currently thought
to aid the scission of the vesicle from the parent membrane.
Dynamin may be considered to catalyze this change either by
recruiting effector enzymes like endophilin (9, 10) that have
lipid-modifying activity or by an intrinsic mechanochemical
function (11). Whatever the exact mode of dynamin function in
the facilitation of endocytic vesicle scission, it is clear that the
assembly and GTP-binding properties of dynamin are critical
to the process of endocytosis in vivo.
Dynamin mediates endocytosis in concert with various other
molecules, viz. amphiphysin, endophilin, etc. Almost all the
currently identified dynamin-interacting molecules engage the
C-terminal PRD of dynamin. The other domains of dynamin
are also known to participate in dynamin function by mediat-
ing intramolecular interactions within the dynamin molecule
and/or intermolecular interactions within dynamin homo-oli-
gomers. The middle domain has been shown to interact with
the coiled-coil GTPase effector domain (GED) of dynamin (12).
The GED is also known to interact with the N-terminal GTP-
binding domain of dynamin (13) and to act as an internal
GTPase-activating factor for dynamin. In addition, the GED is
thought to interact with the GED of other dynamin molecules,
aiding oligomerization of dynamin (8). The PH domain of dy-
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namin interacts with phosphatidylinositol lipids, thereby tar-
geting dynamin to the plasma membrane (14), and may also
interact with the -subunit complex of heterotrimeric GTP-
binding proteins (15). Additionally, the function of dynamin is
potentially regulated by phosphorylation by multiple kinases
(16). The PRD of dynamin contains many sites that engage SH3
domains. The SH3 domains of the tyrosine kinase pp60c-src,
amphiphysin, endophilin, Grb2, intersectin, Abp1, syndapin,
mixed lineage kinase, p85, phospholipase C, and phosphati-
dylinositol 3-kinase are known to interact with the PRD of
dynamin (17). Additional non-SH3 interactors of dynamin are
-adaptin (18) and nucleoside-diphosphate kinase (19). Re-
cently, auxilin and Hsc70 have been identified as the first
non-PRD interactors of dynamin (20).
This study was designed to uncover hitherto unidentified
interactors of dynamin using yeast two-hybrid analysis (21).
We biased our search by using dynamin lacking the C-terminal
PRD (dynaminPRD) as bait in the yeast two-hybrid screen. A
human brain cDNA library was used to screen for interactors of
dynaminPRD. This has led to the identification of several
putative interactors of dynamin. Here, we characterize the
interaction of dynamin with members of the sumoylation cas-
cade. Sumoylation is a post-translational modification mecha-
nistically similar to ubiquitination. Sumo (small ubiquitin-re-
lated modifier) is a 101-amino acid protein that has the
potential (like ubiquitin) to covalently attach to lysine side
chains in target molecules (22–25). This covalent attachment of
Sumo is mediated by a cascade of enzymes known as the E1
(activating), E2 (conjugating), and E3 (ligating) enzymes. The
101-amino acid Sumo polypeptide is proteolytically processed
by a C-terminal hydrolase to a 97-amino acid moiety ending in
a diglycine motif. This mature form of Sumo forms a thiol ester
linkage with a cysteine residue in the activating E1 enzyme
(the SAE1/2 heterodimer in humans) and is subsequently
transferred to the E2 enzyme (Ubc9) to form another thiol ester
linkage. The activated Sumo is ultimately attached to an avail-
able lysine residue in an acceptor polypeptide through the
formation of an isopeptide bond between the C-terminal glycine
residue of Sumo and an -amino group of the lysine. This last
step often requires the participation of E3 ligases, three of
which PIAS (protein inactivator of activated STAT proteins),
RanBP2, and Pc2 are currently known to participate in the
process of sumoylation (26).
Several proteins that are not known to be sumoylated are
known to interact with Sumo. There are reports of noncovalent
interaction of the nucleocapsid proteins of the Tula and Han-
taan hantaviruses with Sumo-1 (27, 28). Also, noncovalent
association of Sumo-1 with the Rad51 and Rad52 proteins has
been shown to have a regulatory role in homologous recombi-
nation in mammalian cells (29).
In this study, we show that the endocytic protein dynamin
interacts noncovalently with members of the sumoylation ma-
chinery and that this interaction inhibits the oligomerization of
dynamin. Consistent with this effect, we found that overexpres-
sion of Sumo in mammalian cells abrogates dynamin-depend-
ent endocytosis. We have narrowed down the region of inter-
action with the sumoylation machinery to be the GED of
dynamin and, by high resolution structural mapping using
NMR, identified the amino acid residues on Sumo-1 responsible
for the interaction.
EXPERIMENTAL PROCEDURES
Cloning of Bait—Amino acids 1–753 of human dynamin-1 were PC-
R-amplified from pTM1-hDyn1 (provided by Dr. Alexander van der
Bliek, UCLA) using primers 5-CCCGAATTCATGGGCAACCGCGG-
C-3 and 5-GCGGAAGCTTGGGCGTGCTGACGG-3. The PCR product
was digested with EcoRI and HindIII and ligated into the pBS-SK
vector between the EcoRI and HindIII sites. From here, the dynamin-
1PRD cDNA was excised using EcoRI and SalI and subcloned into the
pLexA yeast expression vector (Clontech). The construct was confirmed
by multiple restriction digests and DNA sequencing. This clone was
used for screening a human brain cDNA library cloned into the pB42AD
vector (Clontech). Other control plasmids and the host yeast strain were
also provided in the Matchmaker yeast two-hybrid kit procured from
Clontech.
Yeast Two-hybrid Screening—The yeast strain supplied with the kit
and used in this study is EGY48 (MAT, his3, trp1, ura3, LexAop(x6)-
LEU2), a reporter host strain carrying a wild-type LEU2 gene under the
control of LexA operators. Yeast cells were grown or maintained in YPD
medium (1% yeast extract, 2% Bacto-peptone, and 2% glucose) or syn-
thetic dropout (SD) medium lacking the appropriate nutrients to main-
tain the selection. Yeast cells were transformed using the polyethylene
glycol/lithium acetate method as described (30). First, EGY48 cells were
transformed with the p8oplacZ plasmid (-galactosidase reporter plas-
mid), and the transformants were maintained on SD/Glu/Ura plates.
For transformation of the bait plasmid, EGY48(p8oplacZ) colonies were
grown in SD/Glu/Ura medium and subcultured later in YPD medium.
Using the polyethylene glycol/lithium acetate method, competent cells
were made and transformed with 1 g of pLexA-hDyn1PRD and 60 g
of salmon sperm DNA. These transformants were selected and main-
tained on SD/Glu/Ura/His plates. For library screening, the target
plasmid library was sequentially transformed into EGY48-
(p8oplacZpLexA-hDyn1PRD). Library DNA corresponding to 3 
106 colony-forming units was transformed, and positive clones were
screened on SD/Gal/raffinose/Ura/His/Trp/Leu plates. The positive
clones obtained were further narrowed in number by control transfor-
mations, and final clones were examined for lacZ reporter gene expres-
sion using a colony lift filter assay.
Isolation and Characterization of Positive Clones—Plasmid DNA was
extracted from yeast cells using glass beads, and positive clones in the
pB42AD vector were rescued by transforming the DNA into Escherichia
coli strain KC8. (This strain has a defect in trpC, which can be comple-
mented by the TRP1 gene in pB42AD.) Clones thus obtained were
sequenced for their identity and re-tested in yeast two-hybrid assays for
interaction with the human dynamin-1PRD bait plasmid. Using NCBI
BLAST, the identity of each clone was assigned. The screen yielded
full-length Sumo-1 and PIAS-1-(396–651) cloned into the pB42AD plas-
mid. The cDNA for Ubc9 (obtained from Prof. Ronald T. Hay, University
of St. Andrews, St. Andrews, Scotland) was amplified using primers
5-CCCGAATTCATGTCGGGGATCGC-3 and 5-CCGCTCGAGTTAT-
GAGGGCGCAAACTTCTTGG-3 and cloned into the EcoRI/XhoI-cut
pB42AD yeast expression vector.
o-Nitrophenyl--D-galactopyranoside (oNPG) Assay—The strength of
protein-protein interactions observed in yeast cells was quantitated by
oNPG assays as described below. 5 ml of cultures for yeast cotransfor-
mants were grown overnight in SD medium  2% glucose, subcultured
in 3 ml of SD medium  2% galactose and 1% raffinose with 5%
inoculum, and allowed to grow at 30 °C for 8–10 h. oNPG assays were
performed in the A600 nm  0.5–1.0 range following the Clontech proto-
col. Briefly, cells were pelleted and washed with 1.5 ml of Z buffer (16.1
g/liter Na2HPO47H2O, 5.5 g/liter NaH2PO4H2O, 0.75 g/liter KCl, 0.246
g/liter MgSO47H2O, pH 7.0) and later resuspended in 300 l of Z buffer.
100 l of resuspended cells were aliquoted in fresh tubes and subjected
to three freeze/thaw cycles. To these tubes were added 700 l of Z buffer
 0.27% -mercaptoethanol and 160 l of oNPG (4 mg/ml), followed by
incubation at 30 °C for color development. 400 l of 1 M Na2CO3 were
added to stop the reaction. Color development in the supernatant was
measured at A420 nm after centrifuging the tubes at full speed in a
microcentrifuge for 10 min.
Interaction of Dynamin with Sumo-1, Ubc9, and PIAS-1—The cDNA
for Sumo-1 flanked by BamHI and XhoI sites was amplified and ligated
into the pGEXKG vector. This was used to express GST-Sumo-1 in
bacteria. GST-PIAS-(396–651) was expressed in bacteria from pGEX-
4T1 into which amino acids 396–651 of PIAS-1 amplified from
pB42AD-PIAS with flanking EcoRI and XhoI sites had been ligated.
The plasmid pGEX-2T-hUbc9 expressing GST-Ubc9 was a kind gift of
Prof. Ronald T. Hay. For pull-down assays, GST fusion proteins were
expressed in E. coli BL21 cells and immobilized on glutathione-Sepha-
rose 4B beads (Amersham Biosciences); the beads were then incubated
with bovine serum albumin (100 g/ml) to block unreacted sites on the
beads. Rat brain lysate was prepared by homogenizing 0.3–0.5 g of rat
brain tissue in 2.5 ml of Tris-buffered saline (50 mM Tris (pH 7.4) and
150 mM NaCl) containing protease inhibitors in a Dounce homogenizer
and spinning the suspension at 20,800  g for 35 min at 4 °C. The clear
supernatant thus obtained was used as rat brain lysate. In a typical
pull-down reaction, 20 g of recombinant protein-coated beads were
Interaction of Dynamin with Sumo-1 and Ubc931446
 by guest, on O
ctober 7, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
incubated with 200–300 l of rat brain lysate for 30 min with end-over-
end rotation at 4 °C. Beads were washed with Tris-buffered saline, 0.1%
bovine serum albumin, and 0.1% Triton X-100; boiled in 5 Laemmli
buffer; and resolved on 10% SDS-polyacrylamide gel. The gel was pro-
cessed for Western transfer, and the membranes were probed with
anti-dynamin-1 antibodies (Santa Cruz Biotechnology) and developed
using ECL (Amersham Biosciences).
GTP Hydrolysis Assays—GTP hydrolysis by dynamin was assessed
using [-32P]GTP. Dynamin from rat brain was purified by virtue of its
affinity for the SH3 domain of amphiphysin by the method of Stowell et
al. (11). For assembly-stimulated GTPase assays, 0.2 M dynamin in
TMND buffer (20 mM Tris (pH 7.4), 5 mM MgCl2, 150 mM NaCl, and 1
mM dithiothreitol) was incubated with 50 g/ml phosphatidylserine
(Serva Feinbiochemica, Heidelberg, Germany) for 30 min on ice. Vari-
ous amounts of Sumo-1 or Ubc9 were then added to the mixture, which
was further incubated for 30 min on ice. GTP hydrolysis was initiated
by the addition of 200 M GTP (containing [-32P]GTP) and allowed to
proceed for 30 min at room temperature. The total reaction volume was
75–100 l. The reaction was stopped by the addition of 600 l of
acidified 7% charcoal slurry, and the extent of GTP hydrolysis was
measured by counting Pi release in a liquid scintillation counter (Pack-
ard Instrument Co.). Incubation of dynamin with Sumo-1 or Ubc9
before the addition of phosphatidylserine showed the same results.
Oligomerization Assays—Oligomerization of Dynamin was assessed
by the sedimentation assay (31). Dynamin, phosphatidylserine, and
either Sumo-1 or Ubc9 were incubated as described above in TMND
buffer. The reactions (total volume of 150 l) were then centrifuged for
15 min at 100,000  g in a Beckman Ti-42.2 rotor at 4 °C. The super-
natants were precipitated with 10% trichloroacetic acid, and the total
protein from the supernatant and pellet fractions was then visualized
by 10% SDS-PAGE and Coomassie Blue staining. The Sumo-1 and Ubc9
proteins used in the oligomerization and GTPase assays were expressed
in E. coli as hexahistidine-tagged proteins expressed from the pQE32
(QIAGEN Inc.) and pET28a() (Novagen) vectors, respectively.
Expression of Sumo-1 and Ubc9 in Mammalian Cells—The cDNA for
Sumo-1 was PCR-amplified with BamHI and XhoI ends and ligated into
the pcDNA3 vector. The resultant pcDNA3-Sumo-1 clone was digested
with SacI to subclone Sumo-1 into the GFP expression vector pEG-
FPC1. Ubc9 was amplified with EcoRI and XhoI ends and ligated into
the pcDNA3 vector. The resultant pcDNA3-Ubc9 clone was digested
with EcoRI and XhoI to subclone Ubc9 into the EcoRI and SalI sites of
the pEGFPC2 vector to yield GFP-Ubc9. For rescue experiments, a
pcDNA3 construct of full-length rat dynamin-1 (a gift of Dr. Pietro de
Camilli, Yale University) was used. pcDNA3-c-Myc was prepared by
inserting a linker encoding the c-Myc epitope into the HindIII and
BamHI sites of the pcDNA3 vector. The GED (EcoRI/SalI fragment) was
subcloned between the EcoRI and XhoI sites of pcDNA3-c-myc.
The Chinese hamster ovary (CHO) cell line TRVb-1 (with the ham-
ster transferrin receptor knocked out and stably expressing the human
transferrin receptor) (32) was maintained in Ham’s F-12 medium sup-
plemented with 5% fetal bovine serum, 100 g/ml streptomycin, 100
units/ml penicillin, and 100 g/ml Geneticin. Cells were plated on
poly-D-lysine-coated 35-mm dishes (with cover-slip bottoms) 36 h before
transfection. Cells were transfected using FuGENE 6 transfection rea-
gent (Roche Applied Science) with 1.0 g of DNA following the manu-
facturer’s instructions. 24–36 h post-transfection, cells were assayed for
internalization of fluorescently labeled transferrin or RNase A.
Endocytosis Assays—Alexa 568-conjugated transferrin was made up
to 10.5 ng/ml in labeling medium (Ham’s F-12 medium containing, 0.3
mg/ml NaHCO3, 5% fetal bovine serum, and 15 mM HEPES (pH 7.2)).
Transfected TRVb-1 cells were incubated with Alexa 568-conjugated
transferrin for 30 min at 37 °C. Cells were then cooled on ice, and the
excess label was washed with ice-cold buffer A (150 mM NaCl, 5 mM KCl,
1 mM CaCl2, 1 mM MgCl2, and 20 mM HEPES (pH 7.4)). Fluorescent
transferrin was removed from its receptor at the cell surface by multiple
washes with ice-cold acid rinse buffer containing 25.5 mM citric acid,
24.5 mM trisodium citrate, 280 mM sucrose, and 0.01 mM deferoxamine
mesylate (pH 4.0). Cells were fixed at room temperature with 2.5%
paraformaldehyde in buffer A for 20 min, rinsed twice with buffer A,
and used for imaging.
RNase A internalization assays were performed as described (33).
Briefly, Alexa 555-conjugated RNase A was made up to 10 M in
labeling medium. Transfected cells were incubated with labeled RNase
A for 5 min at 37 °C. Cells were cooled on ice, washed twice with ice-cold
buffer A, and fixed as described above.
Microscopy and Image Processing—Confocal imaging was carried out
on a Bio-Rad Radiance 2100 confocal microscope equipped with a Nikon
Eclipse TE300 microscope, factory set dichroics, and lasers. Fluores-
cence images of cells were recorded under sequential excitation and
emission conditions for all probes in a given experiment. All images
were processed for background correction, and those of multiple labeled
cells for cross-talk correction were processed using Metamorph software
(Universal Imaging Corp., West Chester, PA).
Deletion Analysis of Dynamin—To generate different domains of
dynamin, PCR amplification was performed, and a set of overlapping
domains of dynamin was constructed using primer A (5-CCCGAATT-
CATGGGCAACCGCGGC-3), primer B (5-GTGGAGGAATTCAAGAA-
CTTCCG-3) primer C (5-GCAACGAATTCAACAAGAAGAAGACTTC-
AGG-3), primer D (5-CCGGAATTCGCCTCCTTCCTGAGGGCTGG-
3), primer E (5-CTTCTGTCGACTCTGGTTGCTCC-3), primer F (5-
GGTCTCGAGGGCTTTCTC-3), and primer G (5-GGAATTAGCTTGA-
CTGCAGG-3) in the indicated combinations: GTPasemiddle domain
(amino acids 1–505), primers A and E, middle domain (amino acids
313–505), primers B and E; middle domain  PH domain (amino acids
313–636), primers B and F; middle domain  PH domain  GED
(amino acids 313–753), primers B and G; PH domain (amino acids
507–636), primers C and F; PH domain  GED (amino acids 507–753),
primers C and G; and GED (amino acids 618–753), primers D and G.
The PCR products were purified and digested with EcoRI/XhoI or Eco-
RI/SalI and ligated into compatible ends of the pLexA yeast expression
vector.
NMR Spectroscopy—For NMR studies, labeled proteins were pre-
pared from E. coli BL21 cells harboring the GST-Sumo-1 expression
clone grown in M9 minimal medium containing 15NH4Cl and
13C-
labeled glucose. The culture was induced for protein expression at
A600 nm  0.6 with 100 M isopropyl--D-thiogalactopyranoside for 20 h
at 28 °C. The harvested culture was lysed in TEND buffer (20 mM Tris
(pH 7.4), 5 mM EDTA, 150 mM NaCl, and 1 mM dithiothreitol) contain-
ing lysozyme and protease inhibitors. The lysed cells were sonicated
and spun at 100,000  g for 45 min to obtain a clear supernatant. The
supernatant was incubated with glutathione-Sepharose beads for 2 h to
allow binding of overexpressed recombinant protein. The beads were
then washed, and protein was eluted from the column using 20 mM
reduced glutathione in TEND buffer (pH 8.0). Protein was dialyzed
overnight to remove free glutathione and then subjected to digestion by
thrombin to clip off the GST tag. Pure Sumo-1 was obtained by repeat-
edly passing the digest on the glutathione-Sepharose column.
For NMR experiments, singly labeled (15N) and doubly labeled (13C
and 15N) Sumo-1 proteins were prepared as described above. The purity
and monomeric or oligomeric state of the protein and the homogeneity
of the sample were tested by SDS-PAGE analysis and capillary electro-
phoresis. The proteins were concentrated to1 mM and exchanged with
TEND buffer (pH 7.4) by ultrafiltration using a 3-kDa cutoff membrane.
The final volume of the sample was 550 l and contained 10% (v/v)
D2O. Using these proteins, different NMR experiments, viz. two-dimen-
sional 15N HSQC and NOESY and three-dimensional HNN and
HN(C)N (34, 35), NOESY-HSQC (36), total correlation spectroscopy-
HSQC (37), CBCANH (38), CBCACONH (39), and HNCO (40), were
recorded on a Varian 600-MHz NMR spectrometer at 27 °C for reso-
nance assignment and structure determination.
For NMR characterization of the Sumo-GED interaction, 1:1 and 1:2
complexes of Sumo-1 (15N-labeled) with unlabeled GED were prepared
by adding unlabeled GED in small aliquots to a sample of 1 mM
Sumo-1. Two-dimensional HSQC spectra were recorded for both the
complexes and were superimposable. This indicated that the interac-
tion was tight on the NMR time scale and stoichiometric; and hence, no
further addition of GED was required.
RESULTS
Identification of the Members of the Sumoylation Cascade as
Interactors of Dynamin—To identify new interactors of the
100-kDa GTP-binding protein dynamin, a yeast two-hybrid
screen was carried out. Since most known interactors of dy-
namin so far characterized have been identified to interact with
the C-terminal PRD of dynamin, we biased our search by using
truncated dynamin-1 (lacking the C-terminal PRD) as bait in
the screen. A human brain cDNA library was screened using
the yeast two-hybrid technique to search for interactors of
truncated dynamin (referred to as dynaminPRD). The screen
identified many potential interactors. Two of the clones iso-
lated from the screen encoded full-length Sumo-1, and another
two clones represented a fragment of PIAS-1 containing the
C-terminal amino acids 396–651. This was significant because
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both Sumo (small ubiquitin-related modifier) and PIAS (pro-
tein inactivator of underln]activated STAT proteins) are part of
the enzymatic cascade constituting sumoylation (24).
The biochemical cascade involving Sumo requires the action
of three enzymes referred to as E1, E2, and E3. PIAS-1 has
been identified to act as an E3 ligase responsible for the cova-
lent transfer of the 97-amino acid activated Sumo-1 moiety to
acceptor lysine residue(s) in target proteins. The E3 ligase is
also thought to confer specificity for substrates. We thus de-
cided to focus on these clones and examined the interaction of
dynamin with members of the sumoylation cascade more
closely. Most interactors of Sumo also show an interaction with
Ubc9, the E2 enzyme of the sumoylation cascade. Using the
yeast two-hybrid assay, we verified that, in addition to Sumo-1
and PIAS-1, Ubc9 was also an interactor of dynaminPRD
(Fig. 1). As a positive control, we scored the interaction of
dynaminPRD with full-length dynamin.
These interactions were observed by using dynamin fused to
the LexA DNA-binding domain vector (pLexA) and members of
the sumoylation cascade cloned into the activation domain
plasmid (pB42AD). The two plasmids were cotransformed into
yeast cells carrying the reporter gene lacZ. A positive interac-
tion between two proteins is scored by the activation of the
-galactosidase activity of the lacZ reporter gene. As shown in
Fig. 1, reporter gene activation was observed in cotransformed
yeast cells only under conditions in which expression from the
pB42AD plasmid was induced by plating the yeast cells on
galactose-containing medium and not when expression from
the pB42AD plasmid was repressed by maintaining the yeast
cells on glucose-containing medium. As a control, we blunted
an EcoRI restriction site in the pLexA-dynamin construct that
is located at the extreme 5-end of the dynamin cDNA, thereby
putting dynamin out of frame with the LexA fusion partner.
This abolished the interaction with Sumo-1, Ubc9, and PIAS-1
in the yeast two-hybrid assay (data not shown). This verified
that the interaction was indeed dependent on the correct fusion
of dynamin-encoding amino acids downstream of the LexA
fusion partner.
Since the protein levels induced in yeast cells by the two
plasmids are known to be different, we examined the effect of
interchanging the vectors on the observed interaction. Sumo-1,
Ubc9, and PIAS-1 were ligated into the pLexA vector; dynamin
was ligated into the pB42AD vector; and the strength of the
interaction was examined using a liquid culture assay for ac-
tivation of the lacZ reporter gene. Although positive interaction
could be scored between dynamin and Sumo-1 and between
dynamin and Ubc9 using this combination of vectors, the ob-
served strength of interactions was quantitatively weaker than
that seen above (data not shown). Also, the pLexA-PIAS-1
construct displayed activation domain-independent reporter
gene activation and could thus not be used in these studies. In
conclusion, the interactions were more robust and hence more
reliably scored when members of the sumoylation cascade were
kept in the pB42AD vector. The higher levels of expressed
protein from the pB42AD plasmid may account for these dif-
ferences. All subsequent yeast two-hybrid analyses were thus
carried out using Sumo-1, Ubc9, and PIAS-1 in the pB42AD
vector with dynamin (or its truncations) ligated into the pLexA
plasmid.
In Vitro Interactions of Dynamin with Sumo-1, Ubc9, and
PIAS-1—To further support the notion that members of the
sumoylation cascade interact with dynamin, we examined the
ability of purified Sumo-1, Ubc9, and PIAS-1 to interact with
dynamin from rat brain lysates using pull-down assays. We
expressed Sumo, Ubc9, and the C-terminal part of PIAS-1
comprising amino acids 396–651 in E. coli as recombinant
proteins containing an N-terminal GST tag. The GST tag al-
lowed these proteins to be immobilized on glutathione-Sepha-
rose beads. Fig. 2 shows that immobilized GST-Sumo-1, GST-
Ubc9, and GST-PIAS-1 were able to pull down dynamin from
rat brain lysates, whereas immobilized GST alone did not.
Upon multiple repetitions of the assay, we observed that Ubc9
was consistently better than Sumo-1 or PIAS-1 in pulling down
dynamin. The inclusion of the guanine nucleotide GDP or the
non-hydrolyzable analog of GTP did not affect the extent of the
pull down (data not shown).
We have thus established the interaction of dynamin with
FIG. 1. Sumoylation machinery proteins interact with dy-
namin in the yeast two-hybrid system. A, the streaks in duplicate
show yeast cells transformed with two-hybrid plasmids grown under
induced (left panel) and repressed (right panel) conditions for reporter
gene activation. The streaks represent (from top to bottom) yeast
cells cotransformed with pLexA-dynaminPRD and the pB42AD vec-
tor, pB42AD-Sumo-1, pB42AD-Ubc9, pB42AD-PIAS-1-(396–651), or
pB42AD-dynamin. DynaminPRD interacted with Sumo-1, Ubc9, and
PIAS-1. The interaction with full-length dynamin (Dynfl) was used as a
positive control since dynamin is known to oligomerize. B, shown is a
quantitative representation of the strength of these interactions esti-
mated by liquid culture oNPG assays (see “Experimental Procedures”).
FIG. 2. Sumoylation machinery proteins pull down dynamin
from rat brain lysates. GST-Sumo-1, GST-Ubc9, GST-PIAS-1-(396–
651), and GST were immobilized on glutathione-Sepharose beads and
incubated with rat brain lysate (50 g of total protein) for 15 min at 4 °C
to assess their ability to pull down dynamin. Beads thoroughly washed
with buffer were boiled in SDS-PAGE sample buffer, and the solubilized
proteins were resolved on 11% acrylamide gels. The pulled down dy-
namin was detected using anti-dynamin-1 primary antibody on West-
ern blots. Dynamin interacted with members of the sumoylation ma-
chinery, whereas GST alone did not show any interaction. It was also
observed repeatedly that GST-Ubc9 pulled down quantitatively more
dynamin compared with the others, which is consistent with the greater
strength of the Ubc9-dynamin interaction compared with the Sumo-
dynamin and PIAS-dynamin interactions (see Fig. 1B). The results
shown are representative of at least five such assays.
Interaction of Dynamin with Sumo-1 and Ubc931448
 by guest, on O
ctober 7, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
Sumo-1, Ubc9, and PIAS-1 using two independent readouts.
Additionally, the interaction does not seem to be regulated by
the nucleotide (GDP or GTP) bound to dynamin. This is not
surprising, as most known interactors of dynamin are insensi-
tive to its nucleotide status.
Effect of Sumo-1 and Ubc9 on the GTP-hydrolyzing Activity
of Dynamin—To assess the biochemical effect of this interac-
tion on dynamin function, we examined the ability of dynamin
to hydrolyze GTP in the presence of Sumo-1 or Ubc9. Dynamin
function during endocytosis is critically dependent on the oli-
gomerization of dynamin (8). In contrast with the Ras-like
GTPases and the -subunits of heterotrimeric GTP-binding
proteins, dynamin has a low affinity for GTP and GDP, but a
characteristically high rate of GTP hydrolysis (1) that is fur-
ther stimulated by its lipid-dependent oligomerization (41).
Fig. 3A (first through fourth lanes) shows that inclusion of the
lipid phosphatidylserine (50 g/ml) caused oligomerization of
dynamin purified from rat brain as judged by the well estab-
lished ability of oligomerized dynamin to be sedimented at
100,000  g (31). In the absence of phosphatidylserine, dy-
namin was unassembled and thus was present largely in the
supernatant (first and second lanes), whereas inclusion of 50
g/ml phosphatidylserine caused oligomerization of dynamin
and resulted in its transfer to the pellet fraction after a 15-min
spin at 100,000  g at 4 °C (third and fourth lanes). Inclusion
of Sumo-1 or Ubc9 (fifth through eighth lanes) interfered with
the ability of dynamin to form oligomers in the presence of
lipid. Sumo-1 and Ubc9 were recovered in the supernatant
fractions, indicating that they do not bind lipid. Consistent
with these observations, Fig. 3B shows that whereas basal GTP
hydrolysis by dynamin was unaffected by the inclusion of Ubc9
in the assays, lipid-stimulated GTP hydrolysis by dynamin was
abolished by titrating in Ubc9 in the reactions. The addition of
Sumo-1 instead of Ubc9 had the same effect on GTP hydrolysis
(data not shown). Control reactions showed that the inclusion
of even 5-fold higher amounts of bovine serum albumin did not
perturb the GTP hydrolysis by dynamin. Given the importance
of lipid-dependent oligomerization of dynamin for its ability to
mediate endocytosis, it was of interest to examine the effect of
Sumo-1 and Ubc9 overexpression on cellular endocytosis.
Overexpression of Sumo-1 in Cells Abrogates Dynamin-
dependent Endocytosis—To test the functional outcome of
the sumoylation machinery-dynamin interaction, we overex-
pressed Sumo-1 and Ubc9 in a mammalian cell line. CHO cells
stably expressing the human transferrin receptor are capable
of internalizing fluorescently labeled human transferrin. The
uptake of transferrin is a dynamin-dependent process, as the
expression of dominant-negative dynamin abrogates trans-
ferrin uptake in cells (42). We tagged Sumo-1 and Ubc9 with
GFP and examined the effect of their overexpression on the
uptake of Alexa 568-conjugated human transferrin in these
CHO cells. Interestingly, we found that dynamin-mediated up-
take of transferrin was abolished in cells overexpressing either
GFP-Sumo-1 (Fig. 4A) or GFP-Ubc9 (data not shown). In con-
trol experiments, we verified that the uptake of labeled trans-
ferrin was unaffected in cells expressing GFP alone (data not
shown). Fig. 4A shows that only the cells expressing GFP-
Sumo-1 displayed an inhibition of transferrin uptake, whereas
neighboring cells that did not show expression of GFP-Sumo-1
displayed normal transferrin uptake. Thus, consistent with the
ability of Sumo and Ubc9 to inhibit the oligomerization of
dynamin (seen above), their overexpression in cells serves to
down-regulate dynamin-mediated endocytosis most probably
by preventing the proper assembly of endogenous dynamin.
It is possible that overexpression of Sumo-1 and Ubc9 in cells
might deregulate other cellular processes dependent on sumoy-
lation and that these processes could, in principle, indirectly
affect endocytosis. If the observed block in endocytosis is indeed
due to interference of overexpressed Sumo-1 (or Ubc9) with the
functioning of endogenous dynamin, we reasoned that the block
should be relieved by increasing the levels of dynamin in these
cells. We thus expressed dynamin-1 in CHO cells. Consistent
with other reports (43, 44), overexpression of dynamin did not
cause any increased endocytosis of transferrin in CHO cells.
We then cotransfected dynamin and GFP-Sumo-1 into CHO
cells and examined the uptake of transferrin in doubly trans-
fected cells. As shown in Fig. 4B, coexpression of dynamin
(blue) in cells expressing GFP-Sumo-1 (green) resulted in the
rescue of transferrin (red) uptake. This suggests that the effect
of Sumo-1 overexpression on endocytic transferrin uptake is
mediated by the action of Sumo-1 on dynamin.
We also examined the effect of Sumo-1 overexpression on an
endocytic process not dependent on dynamin. For this purpose,
we examined the uptake of RNase A in CHO cells (33). We
found that Sumo-1 expression did not interfere with the fluid-
phase endocytosis of fluorescently labeled RNase A in these
cells (Fig. 4C). Cells expressing GFP-Sumo-1 showed amounts
of internalized Alexa 555-conjugated RNase A equal to cells not
expressing GFP-Sumo-1. These results show that increasing
the amount of Sumo-1 in cells serves to specifically down-
regulate dynamin-mediated endocytosis with no effect on dy-
namin-independent fluid-phase endocytosis.
Dynamin Is Not Sumoylated—We next asked whether
sumoylation of dynamin is responsible for the observed block of
FIG. 3. Interaction with Sumo-1 and Ubc9 disrupts lipid-medi-
ated oligomerization and GTPase activity of dynamin. A, dy-
namin was incubated with the indicated components and subjected to
ultracentrifugation at 100,000  g. Pellet (P) and supernatant (S)
fractions resolved by SDS-PAGE are shown. Oligomerization of dy-
namin was promoted by the inclusion of lipid (50 g/ml phosphatidyl-
serine) as evidenced by more dynamin being present in the third lane
than in the first lane. Further addition of either Sumo-1 or Ubc9
abolished this lipid-mediated oligomerization (fifth and seventh lanes).
B, the effect of Ubc9 addition on basal and lipid-stimulated GTP hy-
drolysis by dynamin was measured. Inclusion of Ubc9 did not affect
basal GTP hydrolysis, but effectively titrated out the lipid-stimulated
GTP hydrolysis by dynamin.
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transferrin uptake. Covalent attachment of Sumo to dynamin
would result in a modified dynamin species migrating at an
apparent molecular mass of 120 kDa. However, anti-dy-
namin-1 Western blots of lysates of CHO cells overexpressing
either Sumo-1 alone or both Sumo-1 and dynamin-1 showed
single bands corresponding to unmodified dynamin-1 and pro-
vided no evidence of sumoylated dynamin. Dynamin pulled
down from rat brain lysates (or from CHO cells transfected
with Sumo and dynamin) using various GST-SH3 domain pro-
teins also did not display any sumoylation.
We have shown that overexpressing the sumoylation ma-
chinery in cells results in down-regulation of dynamin-medi-
ated endocytosis. In the normal physiology of the cell, a sharp
drop in endocytosis is seen at the time of mitosis (45). To
examine whether dynamin sumoylation might underlie this
effect, CHO cells were blocked at different stages of the cell
cycle. Nocodazole (5 g/ml) was used to arrest cells at the onset
of mitosis at the G2/M boundary (46), or alternatively, Taxol
(10 g/ml) was used to arrest cells during mitosis (47). Possible
dynamin sumoylation was examined by probing cell lysates of
these cells with anti-dynamin and anti-Sumo antibodies on
Western blots. However, no bands corresponding to the size of
sumoylated dynamin were detected.
The GED of Dynamin Interacts with the Sumoylation Ma-
chinery—To map the interaction site of Sumo-1, Ubc9, and
PIAS-1 on dynamin, we constructed a panel of dynamin trun-
cations. Dynamin is a modular protein comprising five do-
mains. Running from the N terminus to the C terminus, these
domains are the GTP-binding domain, the middle domain, the
PH domain, the GED, and the PRD. We made deletion con-
structs of dynamin encoding only one or more contiguous do-
mains. These were cloned into the pLexA plasmid, and their
interactions with Sumo-1, Ubc9, and PIAS-1 were examined
using the yeast two-hybrid assay. The results are summarized
in Fig. 5. Only those constructs of dynamin that included the
GED showed interaction with members of the sumoylation
cascade. The GED alone was also capable of interacting with
Sumo-1, Ubc9, and PIAS-1.
We have thus narrowed down the site of interaction of the
sumoylation machinery with dynamin to be the GED of dy-
namin. The GED mediates dynamin oligomerization by GED-
GED intermolecular interactions (7). Taken together, our re-
sults suggest that Sumo-1 and Ubc9 interact with the GED,
thereby preventing the oligomerization of dynamin. This re-
sults in the abrogation of lipid-stimulated GTP hydrolysis by
dynamin in vitro (Fig. 3) and in the block of dynamin-depend-
ent endocytosis in vivo (Fig. 4).
We then wondered whether expression of the dynamin
GED alone in cells could rescue the block of dynamin-depend-
ent endocytosis induced by the overexpression of GFP-
Sumo-1. We constructed Myc-tagged dynamin GED and over-
expressed it in CHO cells. Control experiments established
that expression of Myc-GED did not perturb the uptake of
Alexa 568-conjugated transferrin in these cells. We next co-
transfected plasmids expressing GFP-Sumo-1 and Myc-GED
into CHO cells. Whereas GFP-Sumo-1-expressing cells were
impaired in transferrin uptake, cells coexpressing GFP-
Sumo-1 and Myc-GED exhibited normal endocytic uptake of
transferrin (data not shown). These results support the ob-
servation that the GED of dynamin is the site of noncovalent
interaction with the sumoylation machinery.
Identification of the Surface on Sumo-1 That Interacts with
the GED of Dynamin—Further characterization of the interac-
tion of the dynamin GED with Sumo-1 was obtained by high
resolution NMR experiments. The two-dimensional HSQC
spectrum of a protein represents its “fingerprint” in the sense
that every amino acid residue produces one backbone amide
proton and 15N correlation peak in the spectrum. The position
of every peak is very sensitive to its local environment and
hence is a convenient monitor for residue-specific changes due
to complex formation with ligands or other proteins (48).
Fig. 6A shows the two-dimensional HSQC spectrum (black)
of free 15N-labeled Sumo-1. Sequence-specific assignment of
the individual peaks was obtained by procedures based on
triple resonance three-dimensional HNN and HN(C)N experi-
ments. Fig. 6B shows an illustrative sequential walk for the
stretch Gly19–Lys25 through the HNN spectrum, which allows
assignment of amide proton and 15N chemical shifts of specific
residues. All the peaks in Fig. 6A were thus assigned.
The addition of unlabeled GED to the Sumo-1 sample caused
small but reproducible shifts in the positions of the peaks. The
spectrum of the 1:1 complex of Sumo and GED is shown in red
(Fig. 6A) superposed on the spectrum of Sumo alone (black) to
display residue-specific changes in the peak positions. Clearly,
FIG. 4. Expression of Sumo-1 in CHO cells perturbs dynamin-dependent (but not dynamin-independent) endocytosis. A, cells were
transiently transfected with GFP-Sumo-1 (green) and assayed for the dynamin-dependent endocytic uptake of Alexa 568-conjugated transferrin
(Tfn; red). Cells expressing GFP-Sumo-1 showed an abrogation of transferrin uptake, whereas neighboring cells not expressing GFP-Sumo-1
showed the characteristic perinuclear distribution of endocytosed transferrin. B, the Sumo-1-induced block of endocytosis was rescued by the
concurrent expression of dynamin (Dyn). The uptake of transferrin (red) was restored in cells coexpressing Sumo-1 (green) and dynamin (blue). C,
the dynamin-independent uptake of Alexa 555-conjugated RNase A (red) was unperturbed in cells transiently transfected with GFP-Sumo-1
(green). The uptake of RNase A was the same in all cells. Scale bars  5 m.
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different residues show shifts to varying degrees, which is an
indication of the specificity of the interaction; the amino acid
residues corresponding to those peaks that show large changes
have been labeled. The peak shifts for all the residues have
been quantified and are shown in Fig. 6C. The residues that
show significant shifts (larger than 0.1 ppm) were clearly
strongly influenced by GED binding and hence identify the
binding surface of the protein (49). Thus, we conclude that
Ile22, Lys23, Leu65, Phe66, Glu67, Gly68, Arg70, Ala72, Leu80,
Gly81, Met82, Glu83, Val87, Ile88, and Glu89 of Sumo-1 are re-
sponsible for its interaction with the GED of dynamin.
Next, to determine the topology of the binding surface of
Sumo-1, we determined the three-dimensional structure of the
protein under the same pH and temperature experimental
conditions (pH 7.4 and 27 °C) as used for the interaction stud-
ies; previous studies have investigated the structure and dy-
namics of Sumo-1 under somewhat different experimental con-
ditions (50, 51). For this, we first obtained the assignments of
H, C, C, and CO from a combination of total correlation
spectroscopy-HSQC, CBCANH, CBCACONH, and HNCO ex-
periments. The structure of the molecule was then determined
by DYANA calculations (52) using 585 distance constraints
derived from two-dimensional NOESY and three-dimensional
NOESY-HSQC spectra; 126 dihedral (, ) constraints derived
from the TALOS algorithm (53) using 15N, H, C, C, and CO
chemical shifts; and 48 H-bond distance constraints derived
from deuterium exchange measurements. Fig. 6D shows the
structure of the molecule thus derived as a ribbon diagram.
Sumo-1 consists of five -sheets (1–5) and two -helices (1
and 2), with helix 2 being relatively disordered. This struc-
ture is essentially similar to that reported by Bayer et al. (54)
with regard to secondary structure elements, but has differ-
ences in the overall organization of these elements. It appears
that the structure and dynamics of Sumo-1 are quite sensitive
to experimental conditions, and the details of such structural
and dynamic characterizations will be reported separately.
Residues on Sumo-1 forming the binding surface between
Sumo-1 and GED have been highlighted in Fig. 6D. Ile22 and
Lys23 lie at the beginning of the first -sheet, and Leu65–Gly68,
Arg70, and Ala72 lie in the loop between 3 and 4. Leu80–Glu83
lie in the loop following the mobile helix 2, and Val87–Glu89 lie
at the beginning of 5. Overall, these residues constitute a
relatively flexible pocket, suggesting that small conformational
perturbations within Sumo-1 could easily regulate the interac-
tion between Sumo-1 and the GED of dynamin.
DISCUSSION
In this study, we have identified the 100-kDa endocytic GTP-
binding protein dynamin as an interactor of the sumoylation
machinery. The GED has been identified as the site on dy-
namin that engages the sumoylation machinery. Although we
have no evidence for the covalent attachment of Sumo-1 to
dynamin, we have shown that overexpressing Sumo-1 and
Ubc9 inmammaliancells results indown-regulationofdynamin-
dependent endocytosis of transferrin. This effect is consistent
with our observation that Sumo-1 and Ubc9 abolish the oli-
gomerization of dynamin possibly by sequestering unassembled
dynamin.
It is interesting that the structurally analogous GTP-binding
Mx proteins have also been shown to interact with Sumo-1 (55).
However, covalent attachment of Sumo to the Mx proteins has
not been demonstrated. The septins Cdc3, Cdc11, and Shs1
have also been shown to be sumoylated in a cell cycle-depend-
ent manner (46). Septins are GTP-binding coiled-coil proteins
that are involved in cytokinesis in the budding yeast Saccha-
romyces cerevisiae and, like dynamin, are known to mediate
scission events by forming spiral structures (56) around the
yeast bud necks. Sumoylation of the septins occurs shortly
before the onset of anaphase, and desumoylation occurs
abruptly at cytokinesis (46). We searched for an analogous
stage in the cell cycle for the possible sumoylation of dynamin
in mammalian cells grown in culture. However, no evidence of
the covalent attachment of Sumo-1 to dynamin was seen in
CHO cells that were arrested either before the onset of mitosis
(by nocodazole) or in late mitosis (blocked in cytokinesis by
Taxol).
Sumoylation has been shown to occur on many (although not
all) substrates at lysine residues that lie within a consensus
KXE motif (where  is a hydrophobic amino acid, X is any
amino acid, and E is an acidic amino acid) (57). The amino acid
sequence of dynamin has the stretch VK376ME in the middle
domain corresponding to this consensus motif. We found that
peptides containing this sequence (PFELVKMEFDE) do get
sumoylated in vitro (data not shown). However, we have not
been able to observe the sumoylation of the isolated middle
domain of dynamin when expressed as a recombinant protein
FIG. 5. Deletion analysis of dynamin identified the GED as the site of interaction with Sumo-1 and Ubc9. DynaminPRD was identified
as interacting with the sumoylation machinery. The site of interaction on dynamin was further narrowed down by cloning the various domains of
dynamin either singly or in combination into the pLexA plasmid and testing their interaction with Sumo-1 and Ubc9 cloned into pB42AD. The domains
of dynamin are as follows: GTPase domain (amino acids 1–316), middle domain (MD; amino acids 313–505), PH domain (amino acids 505–636), and
GED (amino acids 618–753). The proline/arginine-rich domain (amino acids 750–864) was not considered here because the interaction was uncovered
using dynaminPRD as bait. It is readily seen that only constructs containing the GED were able to interact with Sumo-1 and Ubc9. In fact, the GED
alone was able to recapitulate the interaction with the sumoylation machinery.
Interaction of Dynamin with Sumo-1 and Ubc9 31451
 by guest, on O
ctober 7, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
in bacteria or the in vitro sumoylation of full-length dynamin
purified from rat brain. We are currently mutating Lys376 in
dynamin and will express the mutant protein in mammalian
cells to test the importance of this site.
It is possible that we have not found the correct conditions
under which dynamin may be sumoylated. The functions of
dynamin are regulated by various phosphorylation events, and
it may be that dynamin is sumoylated only under a specific set
of circumstances. On the other hand, it is conceivable that
dynamin does not act as a covalent acceptor of Sumo-1, but that
it serves to concentrate the sumoylation machinery at its GED,
thereby facilitating the sumoylation of some other substrate(s).
These substrates might be interactors of dynamin. It is of
interest to note in this regard that a recent report has provided
evidence for the nucleocytoplasmic shuttling of some endocytic
proteins (58). Eps15, epsin, clathrin assembly lymphoid mye-
loid leukemia protein, and -adaptin, all of which are signifi-
cantly larger in size than proteins that freely diffuse through
nuclear pores, were seen to be sequestered in the nuclei of cells
blocked in nuclear export. However, no mechanism for the
FIG. 6. Analysis of the Sumo-GED interaction using NMR. A, superposition of the 1H-15N HSQC spectra of 15N-labeled Sumo-1 free (black)
and in complex with unlabeled GED (red). The Sumo-1/GED ratio in the complex was 1:1. Peaks showing considerable shifts upon complex
formation have been labeled. The folded peak of Ala72, which occurs at a distinctly different region of the spectrum, is shown in the inset. B,
illustrative sequential walk through the F1–F3 planes in the HNN spectrum of Sumo-1 at pH 7.4 and 300 K. Sequential connectivities are indicated
for the stretch Gly19–Lys25 along the protein primary sequence. Strips from the relevant planes at appropriate HN chemical shifts are shown. C,
average chemical shift change () versus residue number of 15N-labeled Sumo-1 upon complex formation with unlabeled GED. The average
chemical shift changes for the individual residues were calculated as ((5HN)
2  (N)
2)1/2, where HN and N are the perturbations in amide
proton and 15N chemical shifts for each residue, respectively. A horizontal line has been drawn at a threshold of 0.1 ppm to highlight those residues
that were most affected upon complex formation. D, ribbon diagram of the NMR-derived Sumo-1 structure. 1–5 are the -sheets, and 1 and 2
are the helices in the structure. The residues that showed significant chemical shift perturbations upon binding with GED have been color-coded.
Those that showed chemical shift changes 0.2 ppm are in green, and others are in blue. Together, these identify the binding surface for GED on
Sumo-1.
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nuclear translocation of these normally cytoplasmic proteins
has been identified. Our results raise the intriguing possibility
that sumoylation could mediate the nuclear transport of these
endocytic proteins. These proteins are all known to interact
with dynamin, and their sumoylation could conceivably be fa-
cilitated by concentrating the sumoylation machinery on dy-
namin. Efforts are currently underway in our laboratory to test
this hypothesis.
Many proteins involved in endocytosis (some of which are
interactors of dynamin) are known to be ubiquitinated or to
possess ubiquitin-interacting motifs (59, 60). The ubiquitina-
tion of some of these proteins may be regulated by competing
dynamin-facilitated sumoylation. An example of such competi-
tion between Sumo and ubiquitin has been reported, where the
sumoylation of the transcriptional regulator I	B prevented its
ubiquitination and subsequent proteasomal degradation (61).
The best characterized function of ubiquitination is to target
ubiquitinated proteins for proteasomal degradation, although
proteasome-independent events such as changes in protein lo-
calization and activity are also being uncovered (62). Monou-
biquitination is being appreciated as an important regulator of
endocytosis (63). Sumoylation may play a part in endocytosis
by acting as an antagonist of some of these monoubiquitination
events. Sumoylation is known to enhance the stability of its
target proteins or to modulate their subcellular localization
(25). Even more striking are the growing number of reports
suggesting that noncovalent interactions of Sumo with a num-
ber of molecules may also be of biological significance (27, 28,
29).
Dynamin has also gained recognition as a molecule whose
activity is required for the activation of the MAPK cascade
subsequent to the engagement of cell-surface G-protein-cou-
pled receptors (64, 65). The exact role of dynamin in this path-
way is still open to debate. It is clear, however, that dynamin
function is not required at the level of G-protein-coupled recep-
tor internalization (66). It is currently postulated that dynamin
function is required for the correct translocation of activated
MEK in cells. Significantly, it has been shown in Dictyostelium
cells that MEK localization is controlled by a tightly regulated
cycle of sumoylation-desumoylation (67). It is conceivable that
MEK sumoylation could be facilitated by dynamin acting as a
scaffold for the sumoylation machinery. However, it remains to
be established whether the sumoylation of MEK is a general
phenomenon occurring in mammalian cells and, if so, whether
dynamin is involved in this process. The involvement of dy-
namin in the activation of the MAPK cascade could thus re-
quire a non-endocytic role for dynamin. This possibility is also
being currently investigated in our laboratory.
This study is an initial characterization of the interaction of
dynamin with the sumoylation machinery. Using various inde-
pendent readouts, we have established the GED of dynamin as
being an interacting site for Sumo-1, Ubc9, and PIAS-1. Fur-
thermore, using high resolution NMR, we have identified the
residues on Sumo-1 that interact with the GED of dynamin.
Interestingly, the residues on Sumo-1 that participate in its
interaction with the GED are partially the same as those that
interact with Ubc9 (49).2 This suggests that the interaction of
Sumo-1 with Ubc9 and GED might occur sequentially rather
than simultaneously. We speculate that dynamin could con-
ceivably then act as an adapter E3 molecule for the transfer of
Sumo to an acceptor lysine residue. Such a role has been
postulated for the polycomb Pc2 protein (26). Ongoing studies
are examining the effects of mutation of these residues on
Sumo-dynamin interactions. The physiological relevance of the
Sumo-dynamin interaction has yet to be understood fully, and
efforts are currently underway to examine signaling events
downstream of G-protein-coupled receptor activation in Sumo-
1-overexpressing cells.
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